November 1, 2013Future Cardiology
Deactivation of Implantable cardioverter–defibrillators at End of Life
Key result
ICD deactivation at the end of life remains a major clinical challenge, with the incidence of multiple futile shocks in the final hours of life estimated at 8-16%.
Population
Patients with implantable cardioverter-defibrillators (ICDs) approaching the end of life
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Proactive end-of-life ICD planning is warranted to curb futile shocks; leaves open standardized deactivation protocols.
Structured PICO
P
Population
Patients with implantable cardioverter-defibrillators (ICDs) approaching the end of life
I
Intervention
ICD deactivation
ICD deactivation at the end of life is a critical but often delayed discussion, highlighting the need for improved end-of-life care planning in patients with ICDs.
Cite This Study
Pettit et al. (2013) conducted a review in Implantable cardioverter-defibrillators at end of life. ICD deactivation was evaluated. ICD deactivation at the end of life remains a major clinical challenge, with the incidence of multiple futile shocks in the final hours of life estimated at 8-16%.